CD40, but not CD154, expression on B cells is necessary for optimal primary B cell responses

被引:58
|
作者
Lee, BO
Moyron-Quiroz, J
Rangel-Moreno, J
Kusser, KL
Hartson, L
Sprague, F
Lund, FE
Randall, TD
机构
[1] Trudeau Inst Inc, Saranac Lake, NY 12983 USA
[2] Natl Inst Resp Dis, Mexico City, DF, Mexico
[3] Natl Syst Res, Mexico City, DF, Mexico
来源
JOURNAL OF IMMUNOLOGY | 2003年 / 171卷 / 11期
关键词
D O I
10.4049/jimmunol.171.11.5707
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD40 is an important costimulatory molecule for B cells as well as dendritic cells, monocytes, and other APCs. The ligand for CD40, CD154, is expressed on activated T cells, NK cells, mast cells, basophils, and even activated B cells. Although both CD40(-/-) and CD154(-/-) mice have impaired ability to isotype switch, form germinal centers, make memory B cells, and produce Ab, it is not entirely clear whether these defects are intrinsic to B cells, to other APCs, or to T cells. Using bone marrow chimeric mice, we investigated whether CD40 or CD154 must be expressed on B cells for optimal B cell responses in vivo. We demonstrate that CD40 expression on B cells is required for the generation of germinal centers, isotype switching, and sustained Ab production, even when other APCs express CD40. In contrast, the expression of CD154 on B cells is not required for the generation of germinal centers, isotype switching, or sustained Ab production. In fact, B cell responses are completely normal when CD154 expression is limited exclusively to Ag-specific T cells. These results suggest that the interaction of CD154 expressed by activated CD4 T cells with CD40 expressed by B cells is the primary pathway necessary to achieve B cell activation and differentiation and that CD154 expression on B cells does not noticeably facilitate B cell activation and differentiation.
引用
收藏
页码:5707 / 5717
页数:11
相关论文
共 50 条
  • [1] NF-κB is involved in the regulation of CD154 (CD40 ligand) expression in primary human T cells
    Srahna, M
    Remacle, JE
    Annamalai, K
    Pype, S
    Huylebroeck, D
    Boogaerts, MA
    Vandenberghe, P
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 125 (02): : 229 - 236
  • [2] CD154 (CD40 ligand)
    Schönbeck, U
    Mach, F
    Libby, P
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2000, 32 (07): : 687 - 693
  • [3] Rapid down-modulation of CD40 ligand (CD154) on a transfected B cell line induced by CD40 expressing B lymphoma cells.
    Wierda, WG
    Cantwell, MJ
    Kato, K
    Kipps, TJ
    [J]. BLOOD, 1998, 92 (10) : 544A - 544A
  • [4] CD40 and CD154 in cell-mediated immunity
    Grewal, IS
    Flavell, RA
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 : 111 - 135
  • [5] The role of CD40 and CD154/CD40L in dendritic cells
    Ma, Daphne Y.
    Clark, Edward A.
    [J]. SEMINARS IN IMMUNOLOGY, 2009, 21 (05) : 265 - 272
  • [6] Inhibition of CD40–CD154 costimulatory pathway by a cyclic peptide targeting CD154
    Ilaria Deambrosis
    Sara Lamorte
    Fulvia Giaretta
    Lorenzo Tei
    Luigi Biancone
    Benedetta Bussolati
    Giovanni Camussi
    [J]. Journal of Molecular Medicine, 2009, 87 : 181 - 197
  • [7] Expression of CD40 ligand (CD154) in B and T lymphocytes of Hodgkin disease - Potential therapeutic significance
    Clodi, K
    Asgari, Z
    Younes, M
    Palmer, JL
    Cabanillas, F
    Carbone, A
    Andreeff, M
    Younes, A
    [J]. CANCER, 2002, 94 (01) : 1 - 5
  • [8] The CD40/CD154 receptor/ligand dyad
    Schönbeck, U
    Libby, P
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2001, 58 (01) : 4 - 43
  • [9] Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia
    Garlichs, CD
    John, S
    Schmeisser, A
    Eskafi, S
    Stumpf, C
    Karl, M
    Goppelt-Struebe, M
    Schmieder, R
    Daniel, WG
    [J]. CIRCULATION, 2001, 104 (20) : 2395 - 2400
  • [10] Regulatory B cells accelerate hepatocellular carcinoma progression via CD40/CD154 signaling pathway
    Shao, Yan
    Lo, Chung Mau
    Ling, Chang Chun
    Liu, Xiao Bing
    Ng, Kevin Tak-Pan
    Chu, Andrew Chi Yuen
    Ma, Yuen Yuen
    Li, Chang Xian
    Fan, Sheung Tat
    Man, Kwan
    [J]. CANCER LETTERS, 2014, 355 (02) : 264 - 272